1. Mitchell, K. D. and Navar, L. G. (1995) Intrarenal actions of angiotensin II in the pathogenesis of experimental hypertension. In: Hypertension: Pathophysiology, Diagnosis, and Management (Laragh, J. H. and Brenner, B. M., eds.), 2nd ed., Raven, New York, pp. 1437–1450.
2. Navar, L. G., Harrison-Bernard, L. M., Imig, J. D., and Mitchell, K. D. (2000) Renal actions of angiotensin II at AT1 receptor blockers. In: Angiotensin II Receptor Antagonists (Epstein, M. and Brunner, H. R., eds.), Hanley & Belfus, Philadelphia, pp. 189–214.
3. Urata, H., Nishimura, H., and Ganten, D. (1996) Chymase-dependent angiotensin II forming system in humans. Am. J. Hypertens. 9, 277–284.
4. Chen, L. Y., Li, P., He, Q., et al. (2002) Transgenic study of the function of chymase in heart remodeling. J. Hypertens. 20, 2047–2055.
5. Tokuyama, H., Hayashi, K., Matsuda, H., et al. (2002) Differential regulation of elevated renal angiotensin II in chronic renal ischemia. Hypertension 40, 34–40.